Latest Management of cancer Stories
SAN DIEGO, Feb. 19, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Vice President and Controller, Veronica Vallejo has been promoted to Chief Financial Officer effective February 8, 2013. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) "Veronica has been an integral part of our team since the inception of OncoSec and...
TALLAHASSEE, Fla., Feb. 19, 2013 /PRNewswire/ -- Alliance for Access to Cancer Care -- Legislation aimed at increasing access to life-saving, orally administered cancer treatments has gained the support of numerous co-sponsors as it works its way through the Florida House of Representatives and Senate. The bill, titled The Cancer Treatment Fairness Act, would protect patients from having to pay higher out-of-pocket costs for a cancer medication that is taken by mouth than for a...
WASHINGTON, Feb. 14, 2013 /PRNewswire-USNewswire/ -- While advancements in cancer treatment over the last several decades have improved patient survival rates for certain cancers, some patients remain at risk of developing treatment-related leukemia, according to results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH). Chemotherapy is often a highly effective treatment for cancer, but certain drugs have also been shown in a range...
Prostate Cancer Report to be released at National Proton Conference in Washington, DC WASHINGTON, Feb. 13, 2013 /PRNewswire-USNewswire/ -- Ninety-nine percent of proton therapy patients believe they made the best treatment decision for themselves, according to a new data analysis of outcomes and satisfaction of prostate cancer patients. The survey released today is the most comprehensive of its kind to capture health-related quality of life measures for proton therapy, an advanced...
Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new study that shows how insomnia can influence the occurrence of cancer. Toronto, ON (PRWEB) February 11, 2013 Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new study that shows how insomnia can influence the occurrence of cancer. As Bel Marra Health reports in its article...
NEW YORK, Feb. 11, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTC: AEMD), announced today that their February 7th RetailInvestorConferences.com presentation is now available for on-demand viewing. LINK: www.retailinvestorconferences.com> red "register/ watch event now" button Aethlon Medical's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks. About Aethlon Medical Aethlon...
The “Super Drug” in the cancer world refers to a drug that may be used to treat multiple types of cancer and their various strains. There is now an emerging world class sprinter in the race to create the “Super Drug” - Kalos Therapeutics San Diego, CA (PRWEB) February 08, 2013 The pharmaceutical world has been racing for the cure for cancer for decades with what most experts agree is limited success. The current drugs are either so toxic and damaging to the body that many patients...
GILBERT, Ariz., Feb. 7, 2013 /PRNewswire/ -- Banner MD Anderson Cancer Center (Gilbert, Arizona, USA) recently acquired Elekta cancer management solutions, including two Elekta Infinity(TM) radiation therapy systems, each with an Agility(TM)* 160-leaf multileaf collimator (MLC) and a HexaPOD(TM) patient positioning system. The center also purchased new modules for its MOSAIQ® Oncology Information System and Clarity® Soft Tissue Visualization system for image guided radiation...
Mapping the landscape of kinases could aid in new world of personalized cancer treatment When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The proteins are relatively easy to target with drugs and plenty of kinase inhibitors already exist. Now in a new study, University of Michigan Comprehensive Cancer Center researchers assess the complete landscape of a cancer's "kinome" expression and determine which kinases are acting...
NEW YORK, Feb. 6, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTC: AEMD), announced today that Chairman and Chief Executive officer, James Joyce will present at RetailInvestorConferences.com. DATE: February 7, 2013 TIME: 2:00PM EST LINK: www.retailinvestorconferences.com> red "register/ watch event now" button This will be a live, interactive online event where investors are invited to ask the company questions in real-time- both in the presentation hall as well...
